Thank you for your thoughts, @markymarkfl. The trial I am in is with the drug Olaparib. This site will not let me post the link, but here is what it says:

"The purpose of this study is to see if one year of treatment with olaparib is better than observation alone in patients who had pancreatic cancer surgically removed and who have mutations in the BRCA1, BRCA2 or PALB2 genes. Olaparib is a type of anticancer medication called a PARP inhibitor, which may slow down the process cancer cells use to repair their DNA. Cancer cells need to repair their DNA to survive and grow."

It is double blind so I do not know if I am getting the drug or placebo.